Press Releases Patrys Limited

Equities

Delayed Australian S.E. Other stock markets 20:06:34 2024-05-09 EDT			5-day change	1st Jan Change
0.008 ^AUD	0.00%		0.00%	0.00%

04-10	Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment	MT
02-23	Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Patrys secures US patents for antibody technology	23-04-17	AQ
Patrys : Insights Care Magazine \| Interview with Dr James Campbell	22-11-29	PU
Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy	22-11-18	BU
Patrys : INTERVIEW \| Dr James Campbell on Proactive	22-10-16	PU
Patrys : Appendix 4C - Quarterly - 30 June 2022	22-07-27	PU
Patrys : Appendix 4C - Quarterly - 31 March 2022	22-04-27	PU
Patrys : Application for quotation of securities - PAB	22-04-14	PU
New research: Scientists determine structure of a DNA damage ‘First Responder’ protein	22-03-23	PU
Patrys : Appendix 4D - Half Year Accounts - 31 December 2021	22-02-24	PU
Patrys : Application for quotation of securities - PAB	22-02-07	PU
Patrys : ADC Deals Making Headlines	22-02-07	PU
Patrys : Appendix 4C - Quarterly - 31 December 2021	22-01-30	PU
Patrys : Ceasing to be a substantial holder from MQG	21-12-08	PU
Patrys : Application for quotation of securities - PAB	21-12-06	PU
Patrys : Change of Director's Interest Notices x2	21-12-06	PU
Patrys : Application for quotation of securities - PAB	21-12-05	PU
Patrys : Notification regarding unquoted securities - PAB	21-11-22	PU
Patrys : Notification regarding unquoted securities - PAB	21-11-17	PU
Becoming a substantial holder from MQG	21-11-11	PU
Rights Issue Offer Document	21-11-08	PU

No results for this search